14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
EVEX vs SWBI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, Smith & Wesson Brands, Inc. (SWBI) is the stronger overall head-to-head candidate over Eve Holding, Inc. (EVEX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EVEX carries a Unified Composite Score of 41.3/100 (SELL) at $1.70 (N/M Forward P/E, 0.0% operating margin), whereas SWBI carries 31.8/100 (SELL) at $15.80 (11.8x Forward P/E, 6.0% operating margin).
Composite vs. Pillar Nuance: While EVEX currently prints a higher short-term Unified Composite Score (41.3/100 SELL vs. SWBI 31.8/100 SELL), SWBI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (6.0% vs. 0.0% operating margin) and revenue trajectory (+32.3% vs. +0.0% YoY).
Defensive Composite Rating Caution: Although SWBI compares more favorably head-to-head, both EVEX (41.3/100 SELL) and SWBI (31.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: EVEX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile SWBI trades in a Markup technical trend (CONSOLIDATION options phase, RSI 67.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EVEX vs SWBI. Trailing 12-month operating profitability (EVEX 0.0% vs SWBI 6.0%) and valuation multiples (EVEX N/M vs SWBI 11.8x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Aerospace & Defense value chain with $698.2M market capitalization and 6.0% operating margin.
OpEx & R&D Reinvestment20.9% of Rev ($115M)
90D Engineering Disclosures0 Published
Investor FAQ EVEX vs SWBI Key Questions & Quantitative Answers
As of Nov 16, 2026, Smith & Wesson Brands, Inc. (SWBI) is the stronger overall head-to-head candidate over Eve Holding, Inc. (EVEX) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). EVEX carries a Unified Composite Score of 41.3/100 (SELL) at $1.70 (N/M Forward P/E, 0.0% operating margin), whereas SWBI carries 31.8/100 (SELL) at $15.80 (11.8x Forward P/E, 6.0% operating margin). Composite vs. Pillar Nuance: While EVEX currently prints a higher short-term Unified Composite Score (41.3/100 SELL vs. SWBI 31.8/100 SELL), SWBI captures the overall institutional head-to-head verdict (9–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (6.0% vs. 0.0% operating margin) and revenue trajectory (+32.3% vs. +0.0% YoY). Defensive Composite Rating Caution: Although SWBI compares more favorably head-to-head, both EVEX (41.3/100 SELL) and SWBI (31.8/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: EVEX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 42.8); meanwhile SWBI trades in a Markup technical trend (CONSOLIDATION options phase, RSI 67.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SWBI leads the Growth & Scale pillar: EVEX posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with SWBI at +32.3% YoY revenue growth and +86.7% YoY earnings growth on $551M TTM revenue (26.9% gross margin, 6.0% operating margin). On trailing 12-month operating scale, EVEX generates N/A in USD-normalized revenue versus $551M for SWBI. In operating R&D and SG&A reinvestment, EVEX deploys N/A (0 90-day corporate R&D disclosures) versus 20.9% of Rev ($115M) (0 disclosures) for SWBI.
SWBI screens cheaper on headline valuation multiples. EVEX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SWBI trades at 11.8x Forward P/E, 28.8x Trailing P/E, 0.84x PEG, and 1.4x EV/Revenue (14.9% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against EVEX (-300.9% ROE) versus SWBI (6.6% ROE) capital efficiency.
In options market volatility and institutional positioning, EVEX carries 72.3% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (2.71β · 96% Vol realized risk). By comparison, SWBI carries 60.0% implied volatility (50th %ile, Balanced (25th–60th %ile)), a 0.17x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.73β · 50% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.